Related Experiment Video
Updated: Jun 14, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Immature platelet fraction in patients diagnosed with COVID-19
Neha Parashar1, Rashmi J Gupta1, Divya Gupta2
1Department of Clinical Pathology, Lok Nayak Hospital, New Delhi, India.
Insights
COVID-19 patients with low platelet counts showed higher immature platelet fraction (IPF), indicating platelet destruction. This suggests thrombocytopenia in COVID-19 is likely due to peripheral platelet consumption.
Area of Science:
- Hematology
- Virology
- Critical Care Medicine
Background:
- COVID-19, caused by SARS-CoV-2, is linked to thromboembolic events and thrombocytopenia.
- Thrombocytopenia can result from increased platelet destruction/consumption or decreased bone marrow production.
- Immature platelet fraction (IPF) serves as an indicator of peripheral platelet destruction and consumption.
Purpose of the Study:
- To evaluate the immature platelet fraction (IPF) in patients diagnosed with COVID-19.
Main Methods:
- Retrospective analysis of laboratory records from 68 COVID-19 patients admitted to a Delhi tertiary care hospital.
- Platelet parameters including platelet count, mean platelet volume (MPV), IPF, and platelet large cell ratio (P-LCR) were analyzed.
- Statistical significance was determined using SPSS Version 25, with P < 0.05 considered significant.
Main Results:
- Mild thrombocytopenia was observed in 40% of COVID-19 patients.
- Lower platelet counts correlated with significantly higher IPF, MPV, PDW, and P-LCR.
- A significant inverse relationship was found between IPF and platelet count (P < 0.05).
- IPF showed a significant positive correlation with MPV and P-LCR (P < 0.05).
Conclusions:
- Thrombocytopenia in COVID-19 patients is likely attributed to peripheral platelet destruction and consumption.
- Elevated IPF levels may serve as a biomarker for platelet consumption in COVID-19-associated thrombocytopenia.
Background:
The recent pandemic caused by the newly identified virus, SARS-Cov-2 is associated with thromboembolic events. Patients infected with COVID-19 have been found to have thrombocytopenia. A decrease in platelet count may be caused by increased destruction and consumption of platelets or by decreased production of platelets in the bone marrow. Immature platelet fraction (IPF) is a new platelet parameter that is an indicator for peripheral destruction and consumption of platelets.
Objectives:
To assess the immature platelet fraction (IPF) in patients infected with COVID-19.
Materials And Methods:
The present study is a retrospective study where secondary data obtained from previous laboratory records of COVID-positive patients admitted at a tertiary care hospital in Delhi from 4 January to 4 February 2022 was analyzed. Sixty-eight COVID-positive patients were included. Platelet parameters included from the automated hematology analyzer Mindray were platelet count, mean platelet volume (MPV), immature platelet fraction (IPF), and platelet large cell ratio (P-LCR). Data was analyzed using SPSS Version 25. A P value less than 0.05 was considered statistically significant.
Results:
In the present study mild thrombocytopenia was noted in 40% of the patients infected with COVID-19 admitted to the hospital. The median platelet count in these patients was found to be 91,000/mm 3 (64,000-1,31,000). Low platelet count was associated with a significantly higher IPF, MPV, PDW, P-LCR, and a significantly lower PCT as compared to patients infected with COVID-19 with normal platelet count. There was a significant increase in IPF with a decrease in platelet count ( P value < 0.05). A significant increase in IPF was noted with an increase in MPV and P-LCR ( P value < 0.05).
Interpretation And Conclusion:
The present study suggests that thrombocytopenia in patients infected with COVID-19 may probably be due to peripheral destruction and consumption of platelets.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...